Type 2 Diabetes and prediabetes can be reversed with personalized lifestyle education and support from LifestyleRx and LifeLabs
07 nov. 2023 12h00 HE
|
LifeLabs
Toronto, Ontario, Nov. 07, 2023 (GLOBE NEWSWIRE) -- LifeLabs is pleased to announce its partnership with LifestyleRx to offer Canadians greater support in managing their health with prediabetes and...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Studies of Proprietary Platform in Multibillion-Dollar GLP-1 Drug Space
01 nov. 2023 08h30 HE
|
Lexaria Bioscience Corp.
NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “Can Diabetes, Weight-Loss Drugs Get Even...
“We’re never off the clock”: Diabetes Canada launches Let’s Make Time campaign for Diabetes Awareness Month
01 nov. 2023 05h30 HE
|
Diabetes Canada
Toronto, ON, Nov. 01, 2023 (GLOBE NEWSWIRE) -- November is Diabetes Awareness Month and this year, Diabetes Canada is calling on Canadians to show support for people affected by diabetes through the...
Token Communities, Ltd. Announces Milestone Progress on Multiple Fronts
28 sept. 2023 14h34 HE
|
Token Communities Ltd
Elements of Health and Wellness is proud to unveil the latest addition to our product line: Detox Enhancer.
Token Communities, Ltd. Announces New Head of China Operations
09 août 2023 16h28 HE
|
Token Communities Ltd
BRADENTON, Fla., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Token Communities, Ltd. (Symbol: TKCM, “Token Communities” or the “Company”), today announced that the Company’s subsidiary Elements of Health and...
Token Communities, Ltd. Announces Entry into Distribution Agreement
25 juil. 2023 14h04 HE
|
Token Communities Ltd
BRADENTON, Fla., July 25, 2023 (GLOBE NEWSWIRE) -- Token Communities, Ltd. (Symbol: TKCM, “Token Communities” or the “Company”), today announced that the Company’s subsidiary Elements of Health and...
Blood Glucose Monitoring System Market revenue to hit USD 46 Billion by 2033, says Research Nester
13 juil. 2023 07h30 HE
|
Research Nester
New York, July 13, 2023 (GLOBE NEWSWIRE) -- The global blood glucose monitoring system market size is expected to expand at ~10% CAGR from 2023 to 2033. The market is anticipated to garner a revenue...
Token Communities, Ltd. Announces Launch of its First Two Naturopathic Supplements
16 juin 2023 10h16 HE
|
Token Communities Ltd
BRADENTON, Fla., June 16, 2023 (GLOBE NEWSWIRE) -- Token Communities, Ltd. (“Token Communities” or the “Company”), today announced that the Company has launched the first two of its naturopathic...
BioAegis Therapeutics Announces Two Studies Exploring the Role of ‘Inflammation Regulator’ Gelsolin in Type 2 Diabetes
13 avr. 2023 14h03 HE
|
BioAegis Therapeutics
Gelsolin decreased microparticle-driven inflammation and mitigated activation of the NLRP3 inflammasome in type 2 diabetes. Low levels of gelsolin identified in individuals with type 2 diabetes...
Artificial Pancreas Device System (APDS) Market Worth $3.58Bn, Globally, by 2028 at 20.28% CAGR | The Insight Partners
05 avr. 2023 05h52 HE
|
The Insight Partners
Pune, INDIA., April 05, 2023 (GLOBE NEWSWIRE) -- According to our new research study on “Artificial Pancreas Device System Market Forecast to 2028 – by Type and Geography,” the market is expected to...